MRI/MRSI in Risk Assessment of Prostate Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Prostate Cancer
Interventions
OTHER

eMRI/MRSI

Patients will undergo eMRI/MRSI examination. All subjects will be asked to administer a Fleet enema on the day of the study in order to reduce the potential for fecal residue to interfere with imaging acquisition and quality. Upon arrival at the MRI suite, patients will be asked to complete a standard MRI screening form. Patients will be scanned in the supine position. The entire eMRI/MRSI study will be performed within 55-60 minutes.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00582543 - MRI/MRSI in Risk Assessment of Prostate Cancer Patients | Biotech Hunter | Biotech Hunter